Science • Medicine

AstraZeneca: US trial confirms vaccine safety

A US trial with over 32,000 participants has shown that the Oxford-AstraZeneca Covid-19 vaccine is both safe and effective, preventing symptomatic infections with a 79% efficacy and severe infections and hospitalizations with a 100% efficacy. The trial has also shown no safety concerns associated with blood clots.

Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.
Card reviewed by: @ericof